We examined two inhibitors of DNA synthesis, hydroxyurea (HU) and aphidicholin (APC), and two inhibitors of prostaglandin cyclooxygenase, indomethacin and flufenamic acid, for their effects on the resorptive responses of fetal rat long-bone cultures to epidermal growth factor (EGF) and parathyroid hormone (PTH).
Introduction
Epidermal growth factor (EGF)' is a single chain polypeptide isolated from mouse submaxillary glands (1) and human urine (2) having multiple biological actions in a variety of tissues (3) (4) (5) (6) . In bone, EGF has been shown to bind to specific high affinity receptors (7, 8) to stimulate bone resorption (7, 9, 10) and to inhibit collagen synthesis (1 1) . The mechanism by which EGF stimulates resorption appears dependent on the culture system used. In newborn mouse calvaria cultures, EGF-stimulated resorption is dependent on prostaglandin synthesis and is inhibited by indomethacin (7, 10) . In contrast, in fetal rat long-bone cultures, EGF-stimulated resorption is not inhibited by indomethacin and is not associated with with an increase in prostaglandin E2 in the culture medium (9) . The effects of EGF on cell replication in bone are also variable. In fetal rat long bones (9) , fetal rat calvaria (1 1), a rat osteosarcoma cell line (12) , and primary cultures ofosteoblastlike cells from perinatal mouse and rat bones (12, 13) , EGF increases DNA synthesis, while in newborn mouse calvaria (7) and in human osteosarcoma cell lines (8) , EGF is not mitogenic.
In the current study we determined the effects that two inhibitors of DNA synthesis, hydroxyurea (HU) and aphidicholin (APC) (14, 15) , had on the resorptive responses of fetal rat longbone cultures to EGF and compared these with their effects on the resorptive response to parathyroid hormone (PTH).
We have previously shown (16) that HU (1 mM) markedly decreased DNA synthesis in osteoclast progenitors (the population of cells in the cultures which replicate, terminally differentiate, and fuse into multinucliated osteoclasts), but that HU does not prevent PTH from stimulating resorption or forming new osteoclasts in fetal rat long-bone cultures.
Methods
Culture technique. Bone organ cultures were performed as previously described (16) (17) (18) (19) . 19-d-old fetal rat forelimb bones labeled in utero with 45Ca were dissected free of surrounding muscle, cartilage, and fibrous tissue. Bones were cultured in 0.5 ml of BGJ medium (Gibco, Grand Island, NY) that was supplemented with 5% fetal bovine serum (HyClone, Logan, UT). All serum had previously been heated to 570C for 3 h and treated with dextran-coated charcoal to remove endogenous stimulators of resorption (16) . Cultures were incubated with 95% air, 5% CO2 at 37°C. We used a 24-h preculture in medium to remove readily exchangeable 45Ca and then cultured the bones in experimental medium for 120 h. Bones that were treated with either cyclooxygenase or DNA synthesis inhibitors had these agents added first to the preculture medium. Cultures were transferred to fresh experimental medium after 48 h. Experiments that only examined bone resorption were terminated by placing the bones in 0.2 ml of 5% trichloroacetic acid (TCA) for 1 h. Aliquots (0.1 ml) of medium and the TCA extract of the bones were counted for 45Ca by liquid scintillation in ACS scintillation fluid (Amersham Corp., Arlington Heights, IL). Bone resorption was assessed as the percentage of total 45Ca that was released into the medium.
DNA synthesis. DNA synthesis was assessed as the rate that
[3H]thymidine was incorporated into the cold acid-insoluble fraction of the bones using previously described techniques (1 1, 16 Ci/mM; New England Nuclear, Boston, MA) was added to each culture.
In these experiments no additional cold thymidine was added to the medium. Experiments were terminated by washing the bones in saline, blotting them on filter paper, and placing them in a counting vial with 0.2 ml of 5% TCA at 4°C. After 1 h, the TCA was removed to another vial and the bones were washed with a second 0.2 ml of cold TCA. Both TCA samples were then pooled and the bones were rinsed with 1 ml of 70% ethanol, air dried, and dissolved in 0. (20) . In these experiments, bones were cultured in groups of four per culture well. At the conclusion of an experiment bones were blotted dry, washed in saline, and extracted in 0.2 ml of 5% TCA for I h at 4°C. Bones were then transferred to 0.5 ml of 0.5 N NaOH for 72 h at room temperature and solubilized on ice using a cell sonicator. Aliquots (0.1 ml) of the solubilized bones were neutralized with 0.1 ml of 0.5 M acetic acid and reacted with 2 ml of 4',6'-diaidino-2-phenylindole (DAPI) (100 ng/ml) in a buffer composed of 100 mM NaCl, 10 mM EDTA, and 10 mM Tris, pH 7.0. A standard curve was constructed using calf thymus DNA in identical solutions. Standards and samples were run in duplicate. Fluorescence of the DAPI was detected at 450 nM using an excitation beam of 360 nM in a fluorescence spectrophotometer (Perkin-Elmer Corp., Norwalk, CT).
Reagents. Purified human and mouse EGF were a gift from Dr. Harry Gregory of Imperial Chemical Industries, Macclesfield Chesire, England. Purified mouse EGF was purchased from Biomedical Technologies Inc., Cambridge, MA. Synthetic bovine parathyroid hormone 1-34 was purchased from Boehringer Mannheim Corp., Indianapolis, IN. All other reagents were from Sigma Chemical Co., St Louis, MO. Stock solutions of EGF and PTH were in 0.001 N HCI containing 0.1% bovine serum albumin. Stock solutions of indomethacin (10 mM) and flufenamic acid (10 mM) were in absolute ethanol. Stock aphidicholin (10 mM) was dissolved in dimethylsulfoxide (DMSO). All stock solutions were diluted 1:1,000 or greater in medium. In experiments using indomethacin, flufenamic acid, or aphidicolin, equivalent concentrations of ethanol or DMSO were added to all groups.
Statistics. Differences were analyzed by the two tailed Student's t test.
Results
The responses ofthe bones to all three preparations of EGF were essentially identical and results have been pooled. EGF stimulated bone resorption at 30 ng/ml after both 48 and 120 h (treated/control ratios 1.53±0.12 and 1.57±0.11, respectively) ( Table I) . Lower concentrations had no significant stimulatory effect on resorption, although after 120 h, 1 ng/ml was slightly inhibitory.
As we have previously found, cultures treated with 1 mM HU alone released significantly less 45Ca than did controls. Addition of EGF to HU-treated cultures stimulated resorption in a dose-dependent manner after 120 h. Although absolute amounts of45Ca released from bones treated with HU and EGF were less than from cultures treated with EGF alone, treated/ control ratios for EGF treated bones were greater and more significant when HU was present because of the decrease in unstimulated resorption. HU treatment did not inhibit cell-mediated resorption completely, since devitalized bones released less 45Ca than did live bones treated with HU (Table II) . In addition, neither EGF nor PTH altered the release of 45Ca from devitalized bone (data not shown). (Table IV) . We found that Values are mean±SE for 5-40 determinations per group cultured for 120 h. * Significant effect of EGF, P < 0.01. * Significant effect of bPTH, P < 0.01. § Significant effect of bPTH, P < 0.05. "Significant effect of EGF, P < 0.05. 1 Significant effect of HU, P < 0.01. ** Significant effect of HU + indomethacin, P < 0.05.
This effect was significant in one set of experiments (Table V) but not in another (Table VI) . In contrast to its effects on EGFmediated resorption in the absence of HU, indomethacin, in the presence of HU, blocked the resorptive response to EGF but had little effect on the response to PTH either at 100 ng/ml, a concentration which produced a maximal resorptive response (Table V) , or 1 ng/ml, a concentration which produced a resorptive response similar in magnitude to that of 30 ng/ml EGF (Table VI) . Because HU inhibited the resorption in unstimulated cultures, the magnitude of the resorptive response to 1 ng/ml PTH, measured as a treated over control ratio, was significantly greater in bones treated with HU or HU plus indomethacin than in controls. We have also found that medium containing 1 mM HU, 1 gM indomethacin, and 30 ng/ml EGF did not block the resorptive response of the cultures to PTH (data not shown).
In the presence of HU, indomethacin again blocked the inhibitory effects of PTH on 3H-counts in the cold acid-extractable fraction (Table V) . The effects of indomethacin on EGF-mediated resorption in HU-treated cultures appeared to be related to the inhibition ofprostaglandin synthesis since flufenamic acid, an unrelated inhibitor of prostaglandin cyclooxygenase (21), also inhibited the resorptive response of the cultures to EGF when HU was present in the medium but had little effect on the response to PTH (Table VII) .
To further determine the relationship between DNA synthesis and EGF-mediated resorption, we examined the effects of aphidicolin, an inhibitor of DNA synthesis that is unrelated to HU in either its structure or mechanism of action (15) . As with HU, APC (10 ng/ml) decreased [3H]thymidine incorporation into the cold acid-insoluble fraction ofthe bones by >90% (Table VIII) . However, APC also decreased the incorporation of [3H]thymidine into the cold acid-extractable fraction by 25-50% and hence, its inhibitory effect on DNA synthesis may not have been as great as those of HU. The effects of APC on resorption were also different from those of HU. In the absence of prostaglandin cyclooxygenase inhibitors, APC decreased unstimulated resorption, completely blocked the resorptive response to EGF, but did not significantly affect resorption stimulated by PTH.
Discussion
These experiments again demonstrate that both EGF and PTH stimulate bone resorption in fetal rat long-bone cultures through (16) These results imply that the major resorptive effects of PTH on fetal rat long bone cultures are independent of the state of cell replication, but that the response to EGF is not, and therefore that the mechanisms regulating the resorptive effects of EGF differ from those of PTH. Since both HU in the presence of cyclooxygenase inhibitors and aphidicolin alone specifically blocked resorption stimulated by EGF, it appears that continued cell replication is necessary for at least one component of the EGF-mediated resorptive response of fetal rat long-bone cultures. Similarly, the rate that 45Ca is released from unstimulated cultures also appears to be dependent to some degree on continued DNA synthesis, since both HU and APC inhibited this value.
The mechanism by which HU altered the resorptive response to EGF from one that was independent ofprostaglandin synthesis to one that was inhibitable by either indomethacin or flufenamic acid is unknown. HU has been shown to induce both the in vitro and in vivo differentiation of erythroblastic cells (22) (23) (24) . Therefore, HU could have caused a subpopulation of cells in the fetal rat long-bone cultures to differentiate into a phenotype which was similar to that of cells in newborn mouse calvaria which respond to EGF with enhanced prostaglandin production.
Matsuda et al. (25) have found that HU can alter the intracellular processing ofthe EGF receptor complex. Since processing of the EGF receptor complex may be important for producing biologic responses to EGF (26), alterations in this process could also be involved in the effects we observed.
Finally, increased prostaglandin production can be seen after cell injury (27) . Since cultures treated with HU and EGF had the highest rates of decline in DNA content, the resorptive response to EGF of HU-treated cultures could have been influenced by prostaglandins that were synthesized in response to the higher rates of cell injury and death which occurred in this group.
Recently, the peptide, transforming growth factor alpha (TGF-alpha), which binds and activates the same receptor as EGF, was found to stimulate bone resorption in vitro (28-30). As with EGF, TGF-alpha-mediated resorption is dependent on prostaglandin synthesis in newborn mouse calvaria cultures and independent of prostaglandin synthesis in fetal rat long-bone cultures. TGF-alpha is synthesized and released from a number of neoplasms including the Rice Leydig Cell Tumor, a malignancy which produces humorally mediated hypercalcemia in rats (31) . Antibodies to the EGF receptor block the in vitro bone resorbing activity of supernatants derived from cultured Rice Leydig cells (32) . Hence, production of TGF-alpha in vivo may be a mechanism regulating the hypercalcemia that is associated with this tumor. Similar TGF-alphalike factors are also produced by human malignancies (33) and, therefore, studies ofthe mechanisms regulating the resorptive response to EGF in vitro may provide some insight into the mechanisms regulating human malignant hypercalcemia (34) .
